In this episode, we interview Dr. Steven Pearson, the founder and President of the Institute for Clinical and Economic Review (ICER). Over the past 16 years, ICER has evolved from a Harvard research program to the independent authority on cost-effectiveness and value of new drugs. Dr. Pearson has been an advocate of “Fair Pricing for Fair Access” and in January 2023, ICER published their 2nd Annual Assessment of Barriers to Fair Access Within US Commercial Insurance Prescription Drug Coverage.

Dr. Steven Pearson, Founder, President, Institute for Clinical and Economic Review (ICER)

Institute for Clinical and Economic Review (ICER)

Barriers to Fair Access Report 

Gross-to-Net Bubble

Like this episode and want to hear more? Check out our past episodes here!

Do you have a prescription for better access? Share your ideas with us at [email protected]

Follow us on social media! We’re on YouTube, LinkedIn and @RX4BetterAccess (X)